We are actively working to ensure that the voice of oncology in South Carolina is heard. Explore our website for the latest updates in oncology and healthcare-related legislation in South Carolina, discover SCOS' advocacy on the state and federal level, and more.
SCOS values your input. Help us make a difference in our state. Do you know a South Carolina State Legislature member? Do you have an issue you want brought to the attention of the state legislature? Please contact us with all questions and comments.
February 5, 2021
This week, the Senate and House of Representatives convened in statewide session (Senate in perfunctory session on Tuesday) to consider major legislation on the calendars, elect judges and continue focusing on subcommittee and full committee work. The Senate held extensive debate on H.3707, a funding bill addressing the distribution and administration of COVID-19 vaccines, along with S.516, a new bill which would move teachers and school staff to Phase 1a as “mission-critical workers” to receive vaccines with the caveat of all school districts offering 5-day-a-week in-person instruction by March 2.
SCOS Joins Coalition Letter Urging Addition of the Cures 2.0 Concept Paper Title IV Provisions in the Next COVID-19 Relief Package
The South Carolina Oncology Society (SCOS) joined in a coalition letter to congressional leadership urging that Congress include the 21st Century Cures 2.0 concept paper, recently released by Representatives Diana DeGette and Fred Upton in upcoming legislation to further address the COVID-19 public health crisis. Specifically the letter urges leadership to include policy to provide Medicaid coverage of the routine care costs of clinical trials participation for patients with life-threatening conditions in every state. This critical protection is championed by Representatives Ben Ray Luján and Gus Bilirakis in the Clinical Treatment Act (H.R. 913).
ACCC members were invited to join legal experts and their ACCC colleagues for a one-hour overview and discussion about the Centers for Medicare & Medicaid Services (CMS) final CY 2020 OPPS and PFS rules. The webinar covered key proposals the agency has finalized under the OPPS that will affect next year’s payments for 340B hospitals, excepted off-campus provider-based departments (PBDs), as well as updates to the administration's pricing transparency and drug pricing reform efforts. A recording of this webinar, presentation slides, and rule summaries are available to ACCC members.
ACCC members can access summaries of the final rules here. [Requires Login] Also available, a summary of selected provisions of the CY2020 Hospital Price Transparency Requirements for Hospitals to Make Standard Charges Public final rule. [Requires Login]
View On-Demand Webinar Replay (Requires Login)